How much funding has Dyno Therapeutics raised?

Dyno Therapeutics has raised $109.0M in total funding, most recently a Series A round.

Who are Dyno Therapeutics's investors?

Dyno Therapeutics's investors include Polaris Partners, CRV (Charles River), Andreessen Horowitz, Casdin Capital, GV, Obvious Ventures.

When was Dyno Therapeutics founded?

Dyno Therapeutics was founded in 2018.

Where is Dyno Therapeutics headquartered?

Dyno Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is Dyno Therapeutics in?

Dyno Therapeutics operates in Artificial Intelligence, Biotech, Therapeutics, Healthcare.

How many employees does Dyno Therapeutics have?

Dyno Therapeutics has 51-200 employees.

Dyno Therapeutics

Building high-performance genetic technologies that transform patient lives

Cambridge, United States · Founded 2018 · $109.0M raised

Artificial Intelligence

Biotech

Therapeutics

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2018
Business Model: B2B

Website: dynotx.com
Total Funding: $109.0M
Last Round: $100.0M Series AMay 2021
Rounds: 2

About

Dyno Therapeutics applies AI and high-throughput in vivo experimentation to engineer novel AAV capsids for gene therapy, creating vectors with improved tissue targeting, safety, and efficacy. The company operates a partnership-centric model, licensing its capsid technology to pharma leaders including Novartis, Sarepta, Roche, Spark, and Astellas under deals collectively valued at over $4 billion.

Summary

Dyno Therapeutics is an Artificial Intelligence company based in Cambridge, United States, founded in 2018. It has raised $109.0M in total across 2 rounds, most recently a $100.0M Series A round in May 2021. Investors include Polaris Partners, CRV (Charles River) and Andreessen Horowitz.

LinkedIn X (Twitter)